Pharmacology of the serotonergic anxiolytic tandospirone (SM-3997)
Seymour, P.A.; Mena, E.E.; McLean, S.; Heym, J.
Progress in Clinical and Biological Research 361: 453-460
1990
ISSN/ISBN: 0361-7742 PMID: 1981263 Document Number: 350986
Document emailed within 1 workday
Related Documents
Hsieh, M.T.; Chen, H.C.; Kao, H.C.; Shibuya, T. 1986: Suanzaorentang, and anxiolytic Chinese medicine, affects the central adrenergic and serotonergic systems in rats Proceedings of the National Science Council Republic of China. Part B Life Sciences 10(4): 263-268Yamauchi, M.; Hiraoka, S.; Imanishi, T. 2006: Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors Nihon Shinkei Seishin Yakurigaku Zasshi 26(5-6): 193-198
Cohen, M.L.; Fuller, R.W.; Kurz, K.D.; Parli, C.J.; Mason, N.R.; Meyers, D.B.; Smallwood, J.K.; Toomey, R.E. 1988: Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067 Journal of Pharmacology and Experimental Therapeutics 244(1): 106-112
Vetulani, J.; Byrska, B.; Reichenberg, K. 1979: Head twitches produced by serotonergic drugs and opiates after lesion of the mesostriatal serotonergic system of the rat Polish Journal of Pharmacology and Pharmacy 31(4): 413-423
Miller, L.G.; Thompson, M.L.; Byrnes, J.J.; Greenblatt, D.J.; Shemer, A. 1992: Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine Journal of Clinical Psychopharmacology 12(5): 341-345
Hilberg, T.; Mørland, J. 1999: Serotonergic syndrome. Serotonergic syndrome caused by paroxetine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(11): 1646-1647
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Tsuji, K.; Tajima, O. 2012: Anxiolytic Nihon Rinsho. Japanese Journal of Clinical Medicine 70(1): 42-46
Gonzalez López, F.; Mariño, E.L.; Dominguez-Gil, A. 1986: Pharmacokinetics of tiadipone: a new anxiolytic International Journal of Clinical Pharmacology Therapy and Toxicology 24(9): 482-484
Bakka, A.; Johnsen, A.; Rugstad, H.E. 1974: Consumption of anxiolytic drugs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(27): 1659-1660
Williams, M.; Bennett, D.A.; Loo, P.S.; Braunwalder, A.F.; Amrick, C.L.; Wilson, D.E.; Thompson, T.N.; Schmutz, M.; Yokoyoma, N.; Wasley, J.W. 1989: CGS 20625, a novel pyrazolopyridine anxiolytic Journal of Pharmacology and Experimental Therapeutics 248(1): 89-96
Goudemand, M.; Thomas, P. 1993: Anxiolytic drugs. Principles and rules of use La Revue du Praticien 43(5): 641-645
Korol'kova, T.A.; Sviderskaia, N.E.; Koshtoiants, O.K.; Kozhechkin, S.N.; Kozhedub, R.G.; Petukhova, E.G. 2000: EEG study of the anxiolytic effect of scopolamine Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 86(5): 588-597
Leysen, J.E. 1988: Characterization of serotonergic receptors Revue Medicale de Liege 43(Suppl 1): 12-21
Harto, N.E.; Branconnier, R.J.; Spera, K.F.; Dessain, E.C. 1988: Clinical profile of gepirone, a nonbenzodiazepine anxiolytic Psychopharmacology Bulletin 24(1): 154-160
Jann, M.W. 1988: Buspirone: an update on a unique anxiolytic agent PharmacoTherapy 8(2): 100-116
Bourin, M.; Bradwejn, J. 1992: Cholecystokinin antagonists: anxiolytic drugs of the future Pathologie-Biologie 40(3): 215-217
Nowakowska, E.; Chodera, A.; Kus, K.; Rybakowski, J. 1998: Anxiolytic and memory improving effects of moclobemide Arzneimittel-Forschung 48(6): 625-628